These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37112893)
1. Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients. Roder C; Cosgrave C; Mackie K; Roberts SK; Hellard ME; Wade AJ; Doyle JS Viruses; 2023 Mar; 15(4):. PubMed ID: 37112893 [TBL] [Abstract][Full Text] [Related]
2. Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients. Roder C; Cosgrave C; Mackie K; McNamara B; Doyle JS; Wade AJ Viruses; 2024 Jun; 16(6):. PubMed ID: 38932269 [TBL] [Abstract][Full Text] [Related]
3. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department. Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752 [TBL] [Abstract][Full Text] [Related]
4. On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. Busschots D; Bielen R; Koc ÖM; Heyens L; Dercon E; Verrando R; Janssens F; Van den Bergh L; Van Lint P; Bruckers L; Nevens F; Robaeys G BMC Public Health; 2021 Aug; 21(1):1574. PubMed ID: 34416867 [TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related]
6. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study. Grebely J; Gilliver R; McNaughton T; Conway A; Cunningham E; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Read P Int J Drug Policy; 2023 Apr; 114():103982. PubMed ID: 36863287 [TBL] [Abstract][Full Text] [Related]
7. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883 [TBL] [Abstract][Full Text] [Related]
8. A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia. Harney BL; Whitton B; Paige E; Brereton R; Weiss R; Membrey D; Wade AJ; Iser D; Kemp W; Roberts SK; Spelman T; Sacks-Davis R; Hellard ME; Doyle JS Liver Int; 2022 Mar; 42(3):522-531. PubMed ID: 34821021 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar. Draper BL; Htay H; Pedrana A; Yee WL; Howell J; Pyone Kyi K; Naing W; Sanda Aung K; Markby J; Easterbrook P; Bowring A; Aung W; Sein YY; Nwe N; Myint KT; Shilton S; Hellard M Liver Int; 2021 Nov; 41(11):2578-2589. PubMed ID: 34153155 [TBL] [Abstract][Full Text] [Related]
10. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia. Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882 [TBL] [Abstract][Full Text] [Related]
11. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490 [TBL] [Abstract][Full Text] [Related]
12. Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study. Valerio H; Alavi M; Law M; McManus H; Tillakeratne S; Bajis S; Martinello M; Matthews GV; Amin J; Janjua NZ; Krajden M; George J; Degenhardt L; Grebely J; Dore GJ Clin Infect Dis; 2021 Dec; 73(11):2037-2044. PubMed ID: 34107022 [TBL] [Abstract][Full Text] [Related]
13. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy. Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585 [TBL] [Abstract][Full Text] [Related]
14. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021. Ceccarelli L; Moretti G; Mazzilli S; Petri D; Corazza I; Rizzo C; Lucenteforte E; Vainieri M; Seghieri C; Tavoschi L; BMC Infect Dis; 2024 Mar; 24(1):362. PubMed ID: 38553731 [TBL] [Abstract][Full Text] [Related]
15. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility. MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230 [TBL] [Abstract][Full Text] [Related]
16. Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia. Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ Viruses; 2022 Jul; 14(7):. PubMed ID: 35891474 [TBL] [Abstract][Full Text] [Related]
17. Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost? Prince DS; Girolamo JD; Pipicella JL; Bagatella M; Kayes T; Alvaro F; Maley M; Foo H; Middleton PM; Levy MT Can J Gastroenterol Hepatol; 2022; 2022():3449938. PubMed ID: 36276913 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study. Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671 [TBL] [Abstract][Full Text] [Related]
19. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study. McLeod A; Hutchinson SJ; Smith S; Leen C; Clifford S; McAuley A; Wallace LA; Barclay ST; Bramley P; Dillon JF; Fraser A; Gunson RN; Hayes PC; Kennedy N; Peters E; Templeton K; Goldberg DJ HIV Med; 2021 May; 22(5):334-345. PubMed ID: 33350049 [TBL] [Abstract][Full Text] [Related]
20. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]